IGC Pharma, Inc. (IGC) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 1.15M | 1.79M | 2M | 2.15M | 2.9M | 3.05M | 4.25M | 4.41M | 3.71M | 3.58M | 6.12M | 5.08M |
| Cash & Short-Term Investments | 235K | 938K | 1.13M | 454K | 405K | 470K | 1.55M | 1.82M | 1.2M | 1.38M | 3.12M | 1.95M |
| Cash Only | 207K | 900K | 1.1M | 454K | 405K | 470K | 1.55M | 1.82M | 1.2M | 1.38M | 3.03M | 1.72M |
| Short-Term Investments | 28K | 38K | 25K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 98K | 227K |
| Accounts Receivable | 37K | 75K | 61K | 185K | 77K | 49K | 88K | 79K | 91K | 108K | 137K | 225K |
| Days Sales Outstanding | 15.9 | 17.87 | 59.25 | 36.34 | 17.18 | 24.52 | 18.65 | 28.44 | 30.69 | 55.25 | 57.22 | 27.22 |
| Inventory | 656K | 640K | 658K | 1.35M | 1.36M | 1.43M | 1.51M | 1.51M | 1.54M | 1.93M | 2.64M | 2.64M |
| Days Inventory Outstanding | 222.6 | 195.12 | 1K | 708.39 | 714.12 | 884.82 | 649.16 | 1.27K | 583.92 | 994.34 | 2.07K | 551 |
| Other Current Assets | 201K | 124K | 82K | 148K | 1.04M | 795K | 914K | 960K | 835K | 124K | 102K | 90K |
| Total Non-Current Assets | 8.04M | 7.92M | 7.74M | 5.79M | 5.85M | 6.03M | 6.12M | 6.19M | 6.2M | 7.68M | 10.39M | 10.6M |
| Property, Plant & Equipment | 2.11M | 2.15M | 2.19M | 3.11M | 3.32M | 3.48M | 3.63M | 3.78M | 3.89M | 5.5M | 8.21M | 8.4M |
| Fixed Asset Turnover | 0.15x | 0.16x | 0.07x | 0.10x | 0.10x | 0.07x | 0.11x | 0.07x | 0.06x | 0.03x | 0.04x | 0.07x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 5.27M | 5.1M | 4.88M | 2M | 1.85M | 1.87M | 1.8M | 1.72M | 1.62M | 1.18M | 1.18M | 1.18M |
| Long-Term Investments | 659K | 0 | 0 | 0 | 0 | 679K | 685K | 0 | 686K | 946K | 0 | 0 |
| Other Non-Current Assets | 0 | 669K | 672K | 680K | 681K | 2K | 2K | 688K | 2K | 53K | 998K | 1.02M |
| Total Assets | 9.19M | 9.71M | 9.74M | 7.94M | 8.75M | 9.08M | 10.37M | 10.59M | 9.9M | 11.26M | 16.51M | 15.67M |
| Asset Turnover | 0.03x | 0.04x | 0.02x | 0.04x | 0.04x | 0.03x | 0.04x | 0.03x | 0.03x | 0.01x | 0.02x | 0.03x |
| Asset Growth % | 5.01% | 6.98% | -6.04% | -25.02% | -11.66% | -19.37% | -37.18% | -32.41% | -42.36% | -43.9% | -24.83% | -35.14% |
| Total Current Liabilities | 2.87M | 2.16M | 1.51M | 1.73M | 2.26M | 2.66M | 2.8M | 2.49M | 2.34M | 1.94M | 2.11M | 2.13M |
| Accounts Payable | 1.25M | 1.01M | 628K | 933K | 883K | 835K | 768K | 771K | 773K | 648K | 549K | 672K |
| Days Payables Outstanding | 389.71 | 246.84 | 780.5 | 474.87 | 439.26 | 481.95 | 330.81 | 644.51 | 239.46 | 260.96 | 480.05 | 125.15 |
| Short-Term Debt | 726K | 0 | 0 | 0 | 0 | 127K | 137K | 0 | 127K | 3K | 3K | 3K |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 883K | 1.13M | 877K | 730K | 1.28M | 1.57M | 1.76M | 1.58M | 624K | 416K | 260K | 397K |
| Current Ratio | 0.40x | 0.83x | 1.32x | 1.25x | 1.28x | 1.15x | 1.52x | 1.77x | 1.58x | 1.85x | 2.90x | 2.38x |
| Quick Ratio | 0.17x | 0.53x | 0.89x | 0.47x | 0.68x | 0.61x | 0.98x | 1.16x | 0.93x | 0.86x | 1.65x | 1.14x |
| Cash Conversion Cycle | -151.22 | -33.84 | 282.25 | 269.86 | 292.04 | 427.4 | 336.99 | 657.09 | 375.15 | 788.63 | 1.65K | 453.06 |
| Total Non-Current Liabilities | 191K | 133K | 137K | 140K | 160K | 162K | 190K | 225K | 241K | 270K | 302K | 340K |
| Long-Term Debt | 191K | 131K | 132K | 133K | 134K | 134K | 135K | 136K | 137K | 138K | 139K | 140K |
| Capital Lease Obligations | 0 | 2K | 5K | 7K | 10K | 12K | 35K | 69K | 84K | 115K | 146K | 179K |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 16K | 16K | 20K | 20K | 20K | 17K | 17K | 21K |
| Total Liabilities | 3.06M | 2.29M | 1.65M | 1.86M | 2.42M | 2.82M | 2.99M | 2.71M | 2.58M | 2.21M | 2.41M | 2.47M |
| Total Debt | 926K | 142K | 146K | 202K | 238K | 397K | 441K | 338K | 348K | 380K | 418K | 451K |
| Net Debt | 719K | -758K | -959K | -252K | -167K | -73K | -1.1M | -1.49M | -850K | -998K | -2.61M | -1.27M |
| Debt / Equity | 0.15x | 0.02x | 0.02x | 0.03x | 0.04x | 0.06x | 0.06x | 0.04x | 0.05x | 0.04x | 0.03x | 0.03x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Equity | 6.12M | 7.42M | 8.09M | 6.08M | 6.33M | 6.26M | 7.38M | 7.88M | 7.32M | 9.05M | 14.1M | 13.2M |
| Equity Growth % | -3.3% | 18.6% | 9.69% | -22.87% | -13.54% | -30.86% | -47.67% | -40.31% | -50.9% | -50.58% | -30.01% | -40.1% |
| Book Value per Share | 0.06 | 0.08 | 0.09 | 0.07 | 0.08 | 0.08 | 0.10 | 0.11 | 0.11 | 0.14 | 0.26 | 0.25 |
| Total Shareholders' Equity | 6.12M | 7.42M | 8.09M | 6.08M | 6.33M | 6.26M | 7.38M | 7.88M | 7.32M | 9.05M | 14.1M | 13.2M |
| Common Stock | 139.12M | 138.01M | 135.77M | 131.92M | 130.57M | 129.31M | 128.58M | 127.35M | 124.41M | 123.26M | 122.73M | 119.32M |
| Retained Earnings | -127.29M | -124.89M | -122.83M | -122.34M | -120.74M | -119.59M | -117.76M | -116.04M | -113.67M | -110.78M | -105.19M | -102.74M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -5.71M | -5.7M | -4.85M | -3.5M | -3.5M | -3.46M | -3.44M | -3.43M | -3.42M | -3.42M | -3.44M | -3.38M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |